Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
oral.glp 1 New Trial Shows Oral GLP-1 Aleniglipron May Be the Future BPBEImport Amycretin — a novel Quantity:2+1
Amycretin — a novel obesity treatment that targets both GLP-1 and amylin receptors — has shown early success in phase 1 testing and will be advanced into phase 3 testing. http://ms.spr.ly/6185SLoJD
● Diabetic Retinopathy: In individuals with diabetes, rapid improvements in blood sugar control—sometimes seen with GLP-1 drugs—can exacerbate diabetic retinopathy, a condition that damages the blood vessels in the retina
BPBEImport
Quantity:2+1
A post-hoc age subgroup analysis of SURMOUNT‑1 further showed that tirzepatide reduced fat mass by 33–36% and lean mass by 10–11% across all age groups, resulting in improved body composition
US$ 22.14
US$ 25.19
US$ 22.64
